Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry
Open accessThe DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Abstract
Mass spectrometry plays a very visible role in biopharmaceutical industry, although its use in development, characterization, and quality control of protein drugs is mostly limited to the analysis of covalent structure (amino acid sequence and post-translational modifications). Despite the centrality of protein conformation to biological activity, stability, and safety of biopharmaceutical products, the expanding arsenal of mass spectrometry-based methods that are currently available to probe higher order structure and conformational dynamics of biopolymers did not, until recently, enjoy much attention in the industry. This is beginning to change as a result of recent work demonstrating the utility of these experimental tools for various aspects of biopharmaceutical product development and manufacturing. In this work, we use a paradigmatic protein drug interferon beta-1a as an example to illustrate the utility of mass spectrometry as a powerful tool not only to assess the integrity of higher order structure of a protein drug, but also to predict consequences of its degradation at a variety of levels.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Protein Therapeutics: A Summary and Pharmacological Classification
Leader, B., Baca, Q. J., & Golan, D. E. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2399 · Cited by 2,161 · cited 1×
“While a few of such medicines are based on polysaccharides (2) and nucleic acids (3), protein drugs (4,5) constitute the largest fraction of this segment.”
Interferons at age 50: past, current and future impact on biomedicine
Borden, E. C., Sen, G. C., Uze, G., Silverman, R. H., Ransohoff, R. M., Foster, G. R., & Stark, G. R. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2422 · Cited by 1,154 · cited 3×
“to proceed via IFN binding to the high-affinity receptor IFNAR2, followed by recruitment of the low affinity receptor IFNAR1 (45), Figure 5B.”
InfluentialNative mass spectrometry: a bridge between interactomics and structural biology
Heck, A. J. R. (2008) · Nature Methods · doi:10.1038/nmeth.1265 · Cited by 766 · cited 1×
“A relatively easy and convenient way to assess the predictive value of these conclusions is provided by “native mass spectrometry,” a technique that relies on the unique ability of ESI to preserve noncovalent complexes upon their transition from solution to the gas-phase [ 28 ].”
Runkel, L., Meier, W., Pepinsky, R. B., Karpusas, M., Whitty, A., Kimball, K., Brickelmaier, M., Muldowney, C., Jones, W., & Goelz, S. E. (1998) · Pharmaceutical Research · doi:10.1023/a:1011974512425 · Cited by 304
Cited by
Hydrogen exchange mass spectrometry for studying protein structure and dynamics
Konermann, L., Pan, J., & Liu, Y.-H. (2011) · Chem. Soc. Rev. · doi:10.1039/c0cs00113a · Cited by 838
Analytical tools for characterizing biopharmaceuticals and the implications for biosimilars
Berkowitz, S. A., Engen, J. R., Mazzeo, J. R., & Jones, G. B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3746 · Cited by 529
Self-citationHoude, D., Berkowitz, S. A., & Engen, J. R. (2011) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.22432 · Cited by 375
Self-citationJames, E. I., Murphree, T. A., Vorauer, C., Engen, J. R., & Guttman, M. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00279 · Cited by 305
O’Flaherty, R., Bergin, A., Flampouri, E., Mota, L. M., Obaidi, I., Quigley, A., Xie, Y., & Butler, M. (2020) · Biotechnology Advances · doi:10.1016/j.biotechadv.2020.107552 · Cited by 277
Metadata
- Authors
- Kaltashov, I. A., Bobst, C. E., Abzalimov, R. R., Berkowitz, S. A., & Houde, D.
- Venue
- Journal of the American Society for Mass Spectrometry
- Publisher
- American Chemical Society (ACS)
- Published
- 2010-03-01
- Volume
- 21
- Issue
- 3
- Pages
- 323-337
- ISSN
- 1044-0305 (ISSN-L)
- OpenAlex
- W2016086874
- Cited by
- 92
- References
- 4
- FWCI
- 3.11
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry. https://app.cochat.ai/papers/10.1016/j.jasms.2009.10.013
- The paper
- Kaltashov, I. A., Bobst, C. E., Abzalimov, R. R., Berkowitz, S. A., & Houde, D. (2010). Conformation and dynamics of biopharmaceuticals: Transition of mass spectrometry-based tools from academe to industry. Journal of the American Society for Mass Spectrometry. https://doi.org/10.1016/j.jasms.2009.10.013
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.